U.S. stock futures wobbled, as rising energy prices exacerbated concerns about inflation, and lingering worries about China’s property sector weighed on sentiment. Individual stocks were also seeing muted trading ahead Tuesday’s opening bell. Here’s what is moving:
-
shares fell 7% premarket Tuesday. Shares closed more than 17% higher on Monday after the healthcare device company said results were positive from a study of its tennis elbow treatment.
- Shares of cannabis company
jumped 10% premarket after its wholly-owned subsidiary Canna Cabana received approval to operate in British Columbia.
- Shares of
edged up 1.6% premarket a day after it and partner Ridgeback Biotherapeutics said they have filed an application asking U.S. health regulators to authorize their Covid-19 pill, the next step toward adding a long-sought drug for use at home.
The Merck & Co. campus in Rahway, N.J., July 12, 2018.
Photo:
brendan mcdermid/Reuters
- Digital payments company
was up 1.2% ahead of the bell, with no clear news though the stock was among the trending tickers on Stocktwits.
-
shares rose more than 10% premarket as the battery-grade graphite company approved Phase 1 construction of the Coosa Graphite Project in Alabama.
Chart of the Day
- The sunshine and breezes that make Brazil’s beaches a tourist destination have also drawn a large share of the world’s investment in solar and wind power to the country in recent years.
Write to Caitlin Ostroff at caitlin.ostroff@wsj.com
Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More: Merck, High Tide, Square: What to Watch When the Stock Market Opens